primaquine
Selected indexed studies
- Primaquine derivatives: Modifications of the terminal amino group. (Eur J Med Chem, 2019) [PMID:31472472]
- Primaquine: the risks and the benefits. (Malar J, 2014) [PMID:25363455]
- Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. (Malar J, 2018) [PMID:29499733]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Primaquine derivatives: Modifications of the terminal amino group. (2019) pubmed
- Primaquine: the risks and the benefits. (2014) pubmed
- Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. (2018) pubmed
- Primaquine revisited six decades after its discovery. (2009) pubmed
- Primaquine therapy for malaria. (2004) pubmed
- Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art. (2016) pubmed
- Primaquine for preventing relapses in people with Plasmodium vivax malaria. (2007) pubmed
- Primaquine in vivax malaria: an update and review on management issues. (2011) pubmed
- Mass primaquine treatment to eliminate vivax malaria: lessons from the past. (2014) pubmed
- Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries. (2018) pubmed